8-K ·Filed Jul 16, 2026

CDT

CDT Equity Inc.
BEARISH
Impact 5/10
Horizonimmediate Processed2mo ago SEC0001493152-26-033455
8-K context-dependent: Items 3.03, 7.01
Actionable Insight ▼ Bearish

The reverse split is a short-term fix for a Nasdaq listing requirement, not a fundamental improvement. With a $2M market cap, heavy insider selling, and zero historical reports showing positive stock movement, expect continued weakness. Monitor for failure to maintain bid price above $1.00 post-split or further dilutive events.

DirectionBearish
Confidencehigh
Horizonimmediate
Latest settled — T+20d
CDT ▲ +785.92% at T+20d
SHORT call ✗ call lost -785.92% · α vs SPY -782.30% · entry $0.3550 → $3.15
Next anchor: T+60d in 6d
Latest observation: T+52 +191.01% FF3 residual α
Entry anchored
Jul 15, 06:27 PM ET
via exchange tick
T+1d
-11.72%
call +11.72% · α +10.73%
$0.3134
settled 3mo ago
T+5d
+821.13%
call -821.13% · α -822.80%
$3.27
settled 2mo ago
T+20d
+785.92%
call -785.92% · α -782.30%
$3.15
settled 7w ago
T+60d
—
call — · α —
—
in 6d

Price Chart

Loading chart...

Executive Summary

CDT Equity Inc. filed a 1-for-10 reverse stock split to maintain compliance with Nasdaq's minimum bid-price rule, effective July 17, 2026. Post-split shares outstanding will be ~631,077. This is a distress signal for a $2M market-cap biopharma with recent insider selling of $2.9M, indicating ongoing fundamental challenges.

Key Facts

  • 1-for-10 reverse stock split filed July 15, 2026, effective July 17, 2026 at 5:00 PM ET
  • Post-split shares outstanding: approximately 631,077
  • Reverse split intended to ensure continued compliance with Nasdaq bid-price rule
  • No fractional shares; cash payments for fractional entitlements based on closing price on July 17, 2026
  • Stock continues trading under ticker CDT with new CUSIP 20678X601
  • Recent insider activity: 4 sells totaling $2.9M in last 30 days

Financial Impact

No direct financial data reported; reverse split mechanically reduces share count by 90% but does not change enterprise value or fundamentals

shares outstandingstock price per share

Risk Factors

  • Stock may fail to maintain Nasdaq minimum bid price even after reverse split
  • Continued insider selling pressure
  • Potential further dilution if the company seeks additional financing
  • Low market cap and lack of revenue make the company vulnerable to delisting

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001493152-26-033455
Exhibit: ex3-1.htm0001493152-26-033455
Exhibit: ex99-1.htm0001493152-26-033455
Document: 0001493152-26-033455-index-headers.html0001493152-26-033455
Document: 0001493152-26-033455-index.html0001493152-26-033455
Document: 0001493152-26-033455.txt0001493152-26-033455
8 reports for CDT
Performance horizon
100% Hit rate 5 of 5 directional calls best @ T+20▲ +96.23%Sep 1, 2026
Filters
Rows
Reports for CDT — sortable, filterable
TypeNow
Sep 1, 2026
4w ago
8-K
BEARISH ★ 6/10
$37.00 $1.40▲ +96.23%▲ +97.41%$1.25 (+96.62%)
Jul 31, 2026
9w ago
8-K
BEARISH ★ 8/10
$2.87 $1.68▲ +41.36%▲ +42.60%$1.25 (+56.37%)
Jul 16, 2026
11w ago
8-K
BEARISH ★ 5/10
$0.3550 $3.15▼ −785.92%▼ −782.30%$1.25 (−252.11%)
Jun 29, 2026
13w ago
8-K
BEARISH ★ 7/10
$0.5600 $2.85▼ −408.04%▼ −409.06%$1.25 (−123.21%)
Jun 16, 2026
15w ago
8-K
BEARISH ★ 7/10
$0.6930 $0.3550▲ +48.77%▲ +50.09%$1.25 (−80.38%)
May 6, 2026
21w ago
Press Release
NEUTRAL ★ 4/10
$2.26 $0.8050▼ −64.38%▼ −67.16%$1.25 (−44.69%)
Mar 4, 2026
30w ago
Press Release
MIXED ★ 6/10
$17.70 $5.10▼ −71.19%▼ −66.77%$1.25 (−92.94%)
Feb 24, 2026
31w ago
8-K
BULLISH ★ 7/10
$17.25 $10.88▼ −36.96%▼ −31.72%$1.25 (−92.75%)
Showing 8 of 8

US Market Status

Market Closed — Opens Mon (37h 29m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access